NCT00206947 - The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

Schizophrenia

Interventions

DRUG

donepezil (5-10 mg/day)

Donepezil will be administered in a dose optimized for treatment, to patients who are stabilized on a ziprasidone treatment

DRUG

Placebo

Placebo will be added to the medication of schizophrenia patients who are first stabilized on a ziprasidone treatment

Trial Locations (4)

Dept. of Psychiatry O, Rigshospitalet, Blegdamsvej 9, Copenhagen

Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Dept. F, Bispebjerg Hospital, Copenhagen NV

Psychiatric Center, Glostrup, Glostrup Municipality

Danish Research Center for Magnetic Resonance Imaging, Hvidovre Hospital, Hvidovre